Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease

Justyna Pollok, Joseph Em Van Agteren, Adrian J. Esterman, Kristin V. Carson-Chahhoud

Research output: Contribution to journalReview articlepeer-review

6 Citations (Scopus)

Abstract

Chronic obstructive pulmonary disease (COPD) has been recognised as a global health concern, and one of the leading causes of morbidity and mortality worldwide. Projections of the World Health Organization (WHO) indicate that prevalence rates of COPD continue to increase, and by 2030, it will become the world's third leading cause of death. Depression is a major comorbidity amongst patients with COPD, with an estimate prevalence of up to 80% in severe stages of COPD. Prevalence studies show that patients who have COPD are four times as likely to develop depression compared to those without COPD. Regrettably, they rarely receive appropriate treatment for COPD-related depression. Available findings from trials indicate that untreated depression is associated with worse compliance with medical treatment, poor quality of life, increased mortality rates, increased hospital admissions and readmissions, prolonged length of hospital stay, and subsequently, increased costs to the healthcare system. Given the burden and high prevalence of untreated depression, it is important to evaluate and update existing experimental evidence using rigorous methodology, and to identify effective psychological therapies for patients with COPD-related depression.

Original languageEnglish
Article numberCD012347
Number of pages79
JournalCochrane Database of Systematic Reviews
Volume2019
Issue number3
DOIs
Publication statusPublished - 6 Mar 2019

Bibliographical note

See RN: 14342027 for 8 September 2016 version.

Keywords

  • COPD-related depression
  • chronic obstructive pulmonary disease (COPD)
  • Psychological therapies
  • treatment of depression

Fingerprint

Dive into the research topics of 'Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease'. Together they form a unique fingerprint.

Cite this